Correlation Between Kinnate Biopharma and VectivBio Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kinnate Biopharma and VectivBio Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kinnate Biopharma and VectivBio Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kinnate Biopharma and VectivBio Holding AG, you can compare the effects of market volatilities on Kinnate Biopharma and VectivBio Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kinnate Biopharma with a short position of VectivBio Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kinnate Biopharma and VectivBio Holding.

Diversification Opportunities for Kinnate Biopharma and VectivBio Holding

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Kinnate and VectivBio is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Kinnate Biopharma and VectivBio Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VectivBio Holding and Kinnate Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kinnate Biopharma are associated (or correlated) with VectivBio Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VectivBio Holding has no effect on the direction of Kinnate Biopharma i.e., Kinnate Biopharma and VectivBio Holding go up and down completely randomly.

Pair Corralation between Kinnate Biopharma and VectivBio Holding

If you would invest  1,685  in VectivBio Holding AG on September 28, 2024 and sell it today you would earn a total of  0.00  from holding VectivBio Holding AG or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kinnate Biopharma  vs.  VectivBio Holding AG

 Performance 
       Timeline  
Kinnate Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kinnate Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Kinnate Biopharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
VectivBio Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Kinnate Biopharma and VectivBio Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kinnate Biopharma and VectivBio Holding

The main advantage of trading using opposite Kinnate Biopharma and VectivBio Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kinnate Biopharma position performs unexpectedly, VectivBio Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VectivBio Holding will offset losses from the drop in VectivBio Holding's long position.
The idea behind Kinnate Biopharma and VectivBio Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets